Jennifer A. Wargo
- Oncology top 0.02%
- Molecular Biology top 0.2%
- Immunology top 0.1%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 0.5%
- Co-authors
- Padmanee SharmaAntoni RibasSiwen Hu‐LieskovanBeth A. HelminkVancheswaran GopalakrishnanKeith T. FlahertyAlexandre ReubenAlexandria P. Cogdill
- Topics
- Cancer Immunotherapy and Biomarkers (88 papers)Melanoma and MAPK Pathways (69 papers)Immunotherapy and Immune Responses (53 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Jennifer A. Wargo
252 papers receiving 25.2k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 15.9k
- Molecular Biology 11.4k
- Immunology 8.2k
- Pulmonary and Respiratory Medicine 3.6k
- Cancer Research 2.9k
Countries citing papers authored by Jennifer A. Wargo
This map shows the geographic impact of Jennifer A. Wargo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer A. Wargo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer A. Wargo more than expected).
Fields of papers citing papers by Jennifer A. Wargo
This network shows the impact of papers produced by Jennifer A. Wargo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer A. Wargo. The network helps show where Jennifer A. Wargo may publish in the future.
Co-authorship network of co-authors of Jennifer A. Wargo
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer A. Wargo. A scholar is included among the top collaborators of Jennifer A. Wargo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer A. Wargo. Jennifer A. Wargo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 52 | |
| 4 | 1 | |
| 5 | 43 | |
| 6 | Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancersbreakdown → | 266 |
| 7 | 23 | |
| 8 | 5 | |
| 9 | 41 | |
| 10 | 86 | |
| 11 | 192 | |
| 12 | 96 | |
| 13 | 148 | |
| 14 | A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitorsbreakdown → | 357 |
| 15 | 171 | |
| 16 | 110 | |
| 17 | 184 | |
| 18 | EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenibbreakdown → | 767 |
| 19 | 406 | |
| 20 | Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Functionbreakdown → | 574 |
About Jennifer A. Wargo
Jennifer A. Wargo is a scholar working on Oncology, Immunology and Biological Psychiatry, having authored 263 papers that have together received 25.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (88 papers), Melanoma and MAPK Pathways (69 papers) and Immunotherapy and Immune Responses (53 papers). The work is most often cited by research in Oncology (15.9k citations), Immunology (8.2k citations) and Cancer Research (2.9k citations). Jennifer A. Wargo has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Padmanee Sharma, Antoni Ribas, Siwen Hu‐Lieskovan, Beth A. Helmink, Vancheswaran Gopalakrishnan, Keith T. Flaherty, Alexandre Reuben, Alexandria P. Cogdill, Zachary A. Cooper and Dennie T. Frederick. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.